Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PoCKET: Tolvaptan in ADPKD
NCT03596957Phase 4Unknown
- Start
- Sep 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in autosomal dominant polycystic kidney disease (ADPKD). Status: unknown.
02
Drugs
tolvaptan
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT03596957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596957.